Tennessee HB 2220: Drugs, Prescription - As enacted, authorizes a pharmaceutical manufacturer or its representatives to engage in truthful promotion of off-label uses. - Amends TCA Title 4; Title 7; Title 33; Title 53; Title 63; Title 68 and Title 71.

Bill Text

HB2220
011240
-1-

<BillNo> <Sponsor>

HOUSE BILL 2220
By Sexton C

AN ACT to amend Tennessee Code Annotated, Title 4;
Title 7; Title 33; Title 53; Title 63; Title 68 and Title
71, relative to health care.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:
SECTION 1. The commissioner of health is directed to study issues related to
healthcare access and healthcare status of populations affected by the implementation of the
Tennessee Prescription Safety Act of 2016, Chapter 1002 of the Public Acts of 2016. The
commissioner shall report the findings and any recommendations arising out of the study to the
health committee of the house of representatives and the health and welfare committee of the
senate on or before January 15, 2019.
SECTION 2. This act shall take effect upon becoming a law, the public welfare requiring
it.